BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2844125)

  • 21. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of enzyme-linked immunosorbent assay and radioimmunoassay techniques in determining serum placental protein 14 levels in gynecologic patients.
    Scherbakova LA; Göcze PM; Olefirenko GA; Than GN; Szabò DG; Petrunin DD; Tatarinov YS; Csaba IF
    Tumour Biol; 1991; 12(5):267-71. PubMed ID: 1962148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast.
    Seppälä M; Wahlström T; Bohn H
    Int J Cancer; 1979 Jul; 24(1):6-10. PubMed ID: 225283
    [No Abstract]   [Full Text] [Related]  

  • 24. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies against endometrial protein PP14 and their use for purification and radioimmunoassay of PP14.
    Riittinen L; Närvänen O; Virtanen I; Seppälä M
    J Immunol Methods; 1991 Jan; 136(1):85-90. PubMed ID: 1995715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
    Goldstein DP
    Am J Obstet Gynecol; 1971 Jun; 110(4):583-7. PubMed ID: 4325820
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-resolved immunofluorometric assay for placental protein 14.
    Riittinen L; Stenman UH; Alfthan H; Suikkari AM; Bohn H; Seppälä M
    Clin Chim Acta; 1989 Aug; 183(2):115-23. PubMed ID: 2676243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental protein 14 in human in-vitro fertilization early pregnancies.
    Nylund L; Gustafson O; Lindblom B; Pousette A; Seppälä M; Riittinen L; Akerlöf E
    Hum Reprod; 1992 Jan; 7(1):128-30. PubMed ID: 1551949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Suppression by treatment with danazol and high-dose medroxyprogesterone acetate.
    Telimaa S; Kauppila A; Rönnberg L; Suikkari AM; Seppälä M
    Am J Obstet Gynecol; 1989 Oct; 161(4):866-71. PubMed ID: 2801831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of placenta growth factor in gestational trophoblastic diseases.
    Okamoto T; Niu R; Mizutani S; Yamada S
    Am J Obstet Gynecol; 2003 Jan; 188(1):135-40. PubMed ID: 12548207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABO blood group in patients with malignant trophoblastic disease.
    Sasaki K; Hata H; Nakano R
    Gynecol Obstet Invest; 1985; 20(1):23-6. PubMed ID: 2995210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variations in concentrations of the major endometrial secretory proteins (placental protein 14 and insulin-like growth factor binding protein-1) in assisted conception regimes.
    Arthur ID; Anthony FW; Chard T; Masson GM; Thomas EJ
    Hum Reprod; 1995 Mar; 10(3):664-7. PubMed ID: 7540180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
    Khoo SK; Daunter B
    Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
    Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
    Seki K; Uesato T; Kato K
    Endocrinol Jpn; 1986 Oct; 33(5):727-33. PubMed ID: 3030714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum placental lactogen levels during pregnancy and in trophoblastic disease.
    Samaan N; Yen SC; Friesen H; Pearson OH
    J Clin Endocrinol Metab; 1966 Dec; 26(12):1303-8. PubMed ID: 4289593
    [No Abstract]   [Full Text] [Related]  

  • 38. Secretory endometrial protein PP14 in women with early pregnancy bleeding.
    Ruge S; Sørensen S; Pedersen JF; Lange AP; Byrjalsen I; Bohn H
    Hum Reprod; 1991 Jul; 6(6):885-8. PubMed ID: 1757530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The measurement of secretory endometrial protein PP14 in serum from postmenopausal women receiving unopposed estrogen or continuously combined estrogen/progestogen.
    Byrjalsen I; Riis BJ; Christiansen C
    Gynecol Endocrinol; 1989 Jun; 3(2):143-52. PubMed ID: 2816479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural studies, localization in tissue and clinical aspects of human endometrial proteins.
    Seppälä M; Riittinen L; Julkunen M; Koistinen R; Wahlström T; Iino K; Alfthan H; Stenman UH; Huhtala ML
    J Reprod Fertil Suppl; 1988; 36():127-41. PubMed ID: 3057195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.